Home Microsoft CVE-2009-0231
Back to Microsoft

CVE-2009-0231

Windows - Embedded OpenType Font Engine (T2EMBED.DLL)

Microsoft CVSS 8.8 Updated April 30, 2026

Executive Risk Summary

"The Embedded OpenType Font Engine in Microsoft Windows contains a heap-based buffer overflow vulnerability that allows remote attackers to execute arbitrary code via a crafted name table in a data record. This vulnerability can be exploited by an unauthenticated attacker, potentially leading to code execution and system compromise."

Anticipated Attack Path

  1. 1. Initial Exploitation: Attacker sends a crafted font file to the victim's system
  2. 2. Vulnerability Exploitation: The Embedded OpenType Font Engine processes the malicious font file, triggering the heap-based buffer overflow
  3. 3. Post-Exploitation: Attacker gains arbitrary code execution on the system

Am I Vulnerable?

  • Verify the presence of the T2EMBED.DLL component on the system
  • Check for any suspicious font files or unusual system activity
  • Apply the MS09-029 patch to remediate the vulnerability

Operational Audit Arsenal

Target Type DLL
Target Asset T2EMBED.DLL
Standard Path C:\Windows\System32
PowerShell
# 🛠️ Senior Engineer Universal Audit
# Target: T2EMBED.DLL (DLL)
$Targets = 'T2EMBED.DLL'
$SearchPaths = @("$env:windir\System32", "$env:ProgramFiles", "${env:ProgramFiles(x86)}")

Get-ChildItem -Path $SearchPaths -Include $Targets -Recurse -ErrorAction SilentlyContinue | 
Select-Object FullName, @{Name="Version";Expression={$_.VersionInfo.ProductVersion}}

Patch Impact Forecast

Reboot Required Likely

System restart required, potential disruption to font rendering and system stability

Internal Work Notes

Embedded OpenType Font Engine vulnerability (MS09-029) - potential for arbitrary code execution, apply patch and restart system

Technical Intelligence & Operational Utilities • Delivered Weekly

Intelligence Sources

Related Microsoft Threats

Data compiled from NVD, MSRC, and CISA KEV Catalog. Intelligence synthesized via AI. Scripts provided for diagnostic purposes under MIT License.